Bojian J. Xie

Taizhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 30 publications

Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.

Real-world outcomes of CDK4/6 inhibitors in combination with endocrine therapy as first-line treatment for HR-positive/HER2-negative advanced breast cancer: multicenter evidence from China.

Journal: BMC cancer

Published: January 23, 2026

The xCT/CD98 complex suppresses ferroptosis in pan-cancer via a non-canonical RACK1-mediated iron homeostasis pathway.

The xCT/CD98 complex suppresses ferroptosis in pan-cancer via a non-canonical RACK1-mediated iron homeostasis pathway.

Journal: Cell reports

Published: June 12, 2025

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

5-Hydroxymethylcytosine signatures in circulating cell-free DNA as potential diagnostic markers for breast cancer.

Journal: Biomarkers in medicine

Published: March 26, 2025

TET-mediated 5hmC in breast cancer: mechanism and clinical potential.

TET-mediated 5hmC in breast cancer: mechanism and clinical potential.

Journal: Epigenetics

Published: February 27, 2025

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies.

Antibody-drug conjugates in breast cancer: current resistance mechanisms and future combination strategies.

Journal: Cancer drug resistance (Alhambra, Calif.)

Published: January 26, 2025

A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis.

A potential therapeutic molecule target: lncRNA AK023507 inhibits the metastasis of breast cancer by regulating the WNT/DOCK4/β-catenin axis.

Journal: Breast cancer research and treatment

Published: June 17, 2024

Exploring the Clinical Implications of RPL3 Presence in BRCA-Associated Cancers: Unraveling the Interplay With Cancer Immunity.

Exploring the Clinical Implications of RPL3 Presence in BRCA-Associated Cancers: Unraveling the Interplay With Cancer Immunity.

Journal: Clinical Medicine Insights. Oncology

Published: March 22, 2024

Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody-drug conjugates-induced interstitial lung disease/pneumonitis: An expert consensus in China.

Journal: Cancer

Published: December 28, 2023

Machine learning in the prediction of in-hospital mortality in patients with first acute myocardial infarction.

Machine learning in the prediction of in-hospital mortality in patients with first acute myocardial infarction.

Journal: Clinica chimica acta; international journal of clinical chemistry

Published: December 01, 2023

The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinoma.

The construction and analysis of a prognostic assessment model based on P53-related multi-genes in breast carcinoma.

Journal: European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)

Published: March 13, 2023

Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.

Novel LncRNA AK023507 inhibits cell metastasis and proliferation in Papillary Thyroid Cancer through β-catenin/Wnt Signaling Pathway.

Journal: Biochemical and biophysical research communications

Published: February 27, 2023

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade.

ARIH1 activates STING-mediated T-cell activation and sensitizes tumors to immune checkpoint blockade.

Journal: Nature communications

Published: December 07, 2022

Showing 1-12 of 30

Last Updated: 09/26/2026